What could strengthen or challenge Tyson Foods’s outlook?
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Higher potential upsideImproving expectations
Next-FY EPS estimate change · 30 days
Comparable estimates unavailable
+10% or more+5%0%−5%−10% or less
A matching fiscal period and sufficient coverage are required.
Higher risk of downsideWeakening expectations
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
How this is measured
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
Living FV™
Living Fair Value by QuarterlyIQ
A valuation that evolves as the business changes.
A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.
Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Management context
Stated as a priority in 4 of last 4 quarters. Capital expenditures totaled $397 million in first half of 2026, consistent with guidance of $700 million to $1.0 billion for full fiscal 2026. Management continues to control capex spending to balance maintenance and profit improvement projects. The trajectory is aligned with stated capital expenditure targets.
Delivery assessment Oct 15, 2026
Achieve free cash flow between $1.2B and $1.8B in fiscal 2026
Free cash flow should be $1.2B to $1.8B.
Intact
free cash flow falls below $1.2B in FY26
Free cash flow: $481M
FY2026-Q3; GAAP. Published target: $1.2B to $1.8B free cash flow. Target period is not explicitly aligned with this observation.
Source published Aug 3, 2026481,000,000 USD · calculatedSource reportLast status assessment Oct 15, 2026Measurement source
Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Management context
Stated as a priority in 4 of last 4 quarters. Free cash flow was $432 million in first half of 2026, with guidance consistently targeting $1.3B to $1.7B for full fiscal 2026. Cash from operations and capital expenditures support this range. The trajectory shows management maintaining disciplined capital allocation to meet free cash flow targets.
Delivery assessment Oct 15, 2026
Effective leadership under new CEO and COO
New CEO may improve company balance and strategy.
Under Pressure
Leadership issues cause missed targets or strategic setbacks
Qualitative: Q3 earnings miss + 2026 outlook revision
Q3 earnings miss, 2026 outlook revised down, and securities investigation reported.
Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Management context
Stated as a priority in 4 of last 4 quarters. Revenue was $54.4B in fiscal 2025 and quarterly revenues in 2026 show stable to slightly growing sales, with Q3 2026 revenue at $13.87B. Guidance consistently targets 2% to 4% sales growth for fiscal 2026. The trajectory is delivering consistent top-line growth aligned with management's stated sales increase.
Delivery assessment Oct 15, 2026
Grow profits in Chicken and Prepared Foods segments
Chicken and Prepared Foods profits are rising.
Intact
segment profits fall below $1.5B for Chicken or $1.25B for Prepared Foods in FY26
Direct metric needs a verified mapping
The published measure or accounting basis is not supported by an exact source binding.
Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Management context
Stated as a priority in 3 of last 4 quarters. Chicken segment operating income increased from $460M in 2025-Q1 to $505M in 2026-Q2; Prepared Foods increased from $297M to $348M in same periods. Management consistently highlights these segments as growth drivers. The trajectory shows delivering improved profitability in these segments.
Delivery assessment Oct 15, 2026
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Incoming Evidence
Compare these dated observations with the operating requirements above
Expectations trend
Same fiscal period
FY2028 · fiscal year ending 2028-09-27 · fmp
FY2028 EPS: comparable history unavailable.
FY2028 revenue$56.24B
$56.27B → $56.24B · observed estimates
Exact estimates & source dates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
FY2028 estimate observations · fmp
Snapshot
EPS
Revenue
EPS / revenue analysts
2026-09-28
Unavailable
$56,274,492,516
4 / 8
2026-09-29
Unavailable
$56,274,492,516
4 / 8
2026-09-30
Unavailable
$56,274,492,516
4 / 8
2026-10-01
Unavailable
$56,274,492,516
4 / 8
2026-10-02
Unavailable
$56,274,492,516
4 / 8
2026-10-03
Unavailable
$56,274,492,516
4 / 8
2026-10-04
Unavailable
$56,274,492,516
4 / 8
2026-10-05
Unavailable
$56,274,492,516
4 / 8
2026-10-06
Unavailable
$56,274,492,516
4 / 8
2026-10-07
Unavailable
$56,244,480,016
4 / 8
2026-10-08
Unavailable
$56,244,480,016
4 / 8
2026-10-09
Unavailable
$56,244,480,016
4 / 8
2026-10-10
Unavailable
$56,244,480,016
4 / 8
2026-10-11
Unavailable
$56,244,480,016
4 / 8
2026-10-12
Unavailable
$56,244,480,016
4 / 8
2026-10-13
Unavailable
$56,244,480,016
4 / 8
2026-10-14
Unavailable
$56,244,480,016
4 / 8
2026-10-15
Unavailable
$56,244,480,016
4 / 8
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
0 raises · 1 cuts · 0 unchanged · 0 without a comparable prior
How this is measured
Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Outlook in Brief
The evidence, the remaining questions, and what comes next
What's improving
No recovery evidence is reported in the available driver assessments.
Still unresolved / key risks
Manage capital spending between $700M and $1.0B in fiscal 2026Capital expenditures: $159M
Achieve free cash flow between $1.2B and $1.8B in fiscal 2026Free cash flow: $481M
Effective leadership under new CEO and COOPublished status: Under Pressure
Increase sales by 2% to 4% in fiscal 2026Revenue growth: -0.12%
Grow profits in Chicken and Prepared Foods segmentsDirect metric needs a verified mapping
Next proof point
Nov 16, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Risk observations as of Oct 15, 2026 · 277 daily observations. Historical moves are not forecasts.
Read detailed Outlook Company context, assumptions & risks
Tyson Foods outlook in detail
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
What kind of bet this is
This investment represents a durable compounder with a focus on steady growth. The current thesis state is intact, but recent changes in company momentum and confidence indicate some caution is warranted.
What's priced into Tyson Foods
The market appears to have priced in a justified valuation, though it is considered expensive compared to peers. There is a slight expectations gap, suggesting that the market is not overly optimistic about future performance.
What the fundamentals likely do
Fundamentals are likely to show stable to slightly growing sales, as management targets a 2% to 4% increase in fiscal 2026. However, there is a moderate risk of missing earnings expectations, especially given recent trends in the industry.
What Tyson Foods hinges on
The thesis hinges on management's ability to meet sales and free cash flow targets while navigating potential economic headwinds. Key scenarios include the impact of inflation on consumer staples and the effect of any guidance cuts on market sentiment.
Bottom line
Over the next 1 to 3 years, TSN's performance will depend on management execution and external economic factors. Not investment advice.
Source: QuarterlyIQ weekly Outlook · Week ending Oct 10, 2026 · Carried forward
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
